Crossject: Information relating to the total number of voting rights and shares making up the share capital

Crossject (ISIN: FR0011716265; Ticker: ALCJ), a specialized pharmacy company, has released information on the number of voting rights and shares in its share capital as of May 31, 2024. In accordance with articles 223-16 of the General Regulations of the AMF and L.233-8 II of the Commercial Code, the company has detailed this information.

As of June 6, 2024, the share capital of Crossject consisted of 41,088,344 shares. The total number of theoretical voting rights was 49,339,434 and the number of exercisable voting rights amounted to 49,208,662. It should be noted that 130,772 shares were deprived of voting rights, including the shares held by the society itself.